Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
mercredi, octobre 28
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Onconetix Inc
ONCO
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$0.5979
0.12
25.98%
Dern. MÀJ: Oct 28, 6:48 PM
Get Report
Aperçu
Actualités
Prévisions de résultats
Données financières
Sentiment
Actionnariat
Comparer
Rapport sur les stocks
Fractionnement d'actions:
Onconetix Inc devrait se scinder Friday, November 6, 2026 avec un ratio de 1:10
Onconetix Financials
Onconetix (ONCO) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Onconetix (ONCO) Stock Surges Over 23% Overnight: Why Is It Moving?
Onconetix Inc. shares soared 23.65% after hours following clinical progress updates, new study initiation and developments in prostate cancer diagnostics.
Mohd Haider
PRO
Onconetix Q1 EPS $(6.71) Up From $(225.25) YoY, Sales $21.457K Down From $101.630K YoY
Onconetix (NASDAQ:ONCO) reported quarterly losses of $(6.71) per share. This is a 97.02 percent increase over losses of $(225.25) per share from the same period last year. The company reported $21.457 thousand in sales
Benzinga Newsdesk
PRO
Onconetix Q3 EPS $(6.25) Up From $(249.05) YoY, Sales $303.651K Down From $406.859K YoY
Onconetix (NASDAQ:ONCO) reported quarterly losses of $(6.25) per share. This is a 97.49 percent increase over losses of $(249.05) per share from the same period last year. The company reported $303.651 thousand in sales
Benzinga Newsdesk
PRO
Onconetix Q2 EPS $(4.76) Up From $(2.19 thousand) YoY, Sales $106.494K Down From $704.848K YoY
Onconetix (NASDAQ:ONCO) reported quarterly losses of $(4.76) per share. This is a 99.78 percent increase over losses of $(2.19 thousand) per share from the same period last year. The company reported $106.494 thousand
Benzinga Newsdesk
Dow Surges Over 100 Points; Goldman Sachs Posts Upbeat Earnings
Avi Kapoor
US Stocks Edge Higher; D.R. Horton Posts Upbeat Earnings
Avi Kapoor
